{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:20:42Z","timestamp":1769127642643,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s12350-016-0610-4","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T20:29:27Z","timestamp":1472848167000},"page":"181-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis"],"prefix":"10.1016","volume":"25","author":[{"given":"Sabahat","family":"Bokhari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachelle","family":"Morgenstern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Kinkhabwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetrios","family":"Panagiotou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Castano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"DeLuca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kontak","family":"Andrew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhezhen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew S.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-016-0610-4_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ahj.2012.04.015","article-title":"Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: The Transthyretin Amyloidosis Cardiac Study (TRACS)","volume":"164","author":"Ruberg","year":"2014","journal-title":"Am Heart J"},{"key":"10.1007\/s12350-016-0610-4_bib2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1532-5415.2011.03868.x","article-title":"Transthyretin cardiac amyloidoses in older North Americans","volume":"60","author":"Dharmarajan","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1007\/s12350-016-0610-4_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10741-015-9480-0","article-title":"Cardiac amyloidosis: The great pretender","volume":"20","author":"Rapezzi","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1007\/s12350-016-0610-4_bib4","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","article-title":"Systemic cardiac amyloidoses disease profiles and clinical courses of the 3 main types","volume":"120","author":"Rapezzi","year":"2009","journal-title":"Circulation"},{"key":"10.1007\/s12350-016-0610-4_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/13506129.2014.964858","article-title":"Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis","volume":"21","author":"Sipe","year":"2014","journal-title":"Amyloid"},{"key":"10.1007\/s12350-016-0610-4_bib6","first-page":"127","article-title":"A homozygous transthyretin variant associated with senile systemic amyloidosis: Evidence for a late-onset disease of genetic etiology","volume":"47","author":"Jacobson","year":"1990","journal-title":"Am J Hum Genet"},{"key":"10.1007\/s12350-016-0610-4_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2217\/ahe.13.10","article-title":"Comparison of cardiac amyloidosis due to wild-type and V122I transthyretin in older adults referred to an academic medical center","volume":"9","author":"Givens","year":"2013","journal-title":"Aging Health"},{"key":"10.1007\/s12350-016-0610-4_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10741-014-9462-7","article-title":"Natural history and therapy of TTR-cardiac amyloidosis: Emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs","volume":"20","author":"Casta\u00f1o","year":"2014","journal-title":"Heart Fail Rev"},{"key":"10.1007\/s12350-016-0610-4_bib9","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/PAS.0b013e3182263d74","article-title":"Strong tranthyretin immunostaining, potential pitfall in cardiac amyloid typing","volume":"35","author":"Satoskar","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1007\/s12350-016-0610-4_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3816\/CLML.2010.n.027","article-title":"Pitfalls in the diagnosis of primary amyloidosis","volume":"10","author":"Chee","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1007\/s12350-016-0610-4_bib11","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1182\/blood-2009-07-230722","article-title":"Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens","volume":"114","author":"Vrana","year":"2009","journal-title":"Blood"},{"key":"10.1007\/s12350-016-0610-4_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12350-013-9803-2","article-title":"Nuclear imaging modalities for cardiac amyloidosis","volume":"21","author":"Bokhari","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-016-0610-4_bib13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00259-010-1642-7","article-title":"Usefulness and limitations of 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy","volume":"38","author":"Rapezzi","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-016-0610-4_bib14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/BF00998166","article-title":"Soft-tissue uptake of 99m-Tc-diphosphonate and 99mTc-pyrophosphate in amyloidosis","volume":"16","author":"Janssen","year":"1990","journal-title":"Eur J Nucl Med"},{"key":"10.1007\/s12350-016-0610-4_bib15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jacc.2014.07.209","article-title":"11 C-Pittsburgh B PET imaging in cardiac amyloidosis","volume":"8","author":"Lee","year":"2014","journal-title":"JACC: Cardiovasc Imaging"},{"key":"10.1007\/s12350-016-0610-4_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2967\/jnumed.111.102053","article-title":"In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET","volume":"54","author":"Antoni","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-016-0610-4_bib17","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: A pilot study using 18F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-016-0610-4_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fcvm.2015.00023","article-title":"A routine PET\/CT protocol with simple calculations for assessing cardiac amyloid using 18F-Florbetapir","volume":"2","author":"Osborne","year":"2015","journal-title":"Front Cardiovasc Med"},{"key":"10.1007\/s12350-016-0610-4_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"99mTc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-016-0610-4_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12410-014-9317-6","article-title":"Radionuclide imaging in cardiac amyloidosis: Are nuclear bone tracers a foreseeable future?","volume":"8","author":"Bokhari","year":"2015","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"10.1007\/s12350-016-0610-4_bib21","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s12149-012-0627-y","article-title":"Novel method for quantitative evaluation of cardiac amyloidosis using 201TlCl and 99mTc-PYP SPECT","volume":"26","author":"Yamamoto","year":"2012","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-016-0610-4_bib22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0002-8703(82)90331-3","article-title":"Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis","volume":"103","author":"Wizenberg","year":"1982","journal-title":"Am Heart J"},{"key":"10.1007\/s12350-016-0610-4_bib23","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/archinte.1987.00370060035007","article-title":"Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis","volume":"147","author":"Gertz","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1007\/s12350-016-0610-4_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12350-013-9800-5","article-title":"Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: State of the art review and focus on emerging nuclear techniques","volume":"21","author":"AlJaroudi","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-016-0610-4_bib25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11886-011-0239-5","article-title":"Molecular imaging of amyloidosis: Will the heart be the next target after the brain?","volume":"14","author":"Chen","year":"2012","journal-title":"Curr Cardiol Rep"},{"key":"10.1007\/s12350-016-0610-4_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/01.CIR.56.2.181","article-title":"Follow-up technetium-99m stannous pyrophosphate myocardial scintigrams after acute myocardial infarction","volume":"56","author":"Olson","year":"1977","journal-title":"Circulation"},{"key":"10.1007\/s12350-016-0610-4_bib27","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/01.CIR.51.6.1046","article-title":"Technetium stannous pyrophosphate myocardial scintigrams in patients with chest pain of varying etiology","volume":"51","author":"Willerson","year":"1975","journal-title":"Circulation"},{"key":"10.1007\/s12350-016-0610-4_bib28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0167-5273(87)90209-9","article-title":"Technetium-99m pyrophosphate single-photon emission computed tomography of the heart in familial amyloid polyneuropathy","volume":"14","author":"Karp","year":"1987","journal-title":"Int J Cardiol"}],"updated-by":[{"DOI":"10.1007\/s12350-016-0678-x","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000}}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12350-016-0610-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-016-0610-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123021487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123021487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-016-0610-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-016-0610-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T21:18:04Z","timestamp":1744406284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123021487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1071358123021487"],"URL":"https:\/\/doi.org\/10.1007\/s12350-016-0610-4","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/s12350-016-0678-x","asserted-by":"object"}]},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-016-0610-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}